Ziprasidone: zealous in the treatment of schizophrenia and schizoaffective disorder

被引:0
|
作者
机构
关键词
Schizophrenia; Haloperidol; Risperidone; Olanzapine; Ziprasidone;
D O I
10.2165/00042310-200319040-00001
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 4
页数:3
相关论文
共 50 条
  • [31] ARE SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER SEPARABLE?
    Heinrichs, Walter
    Hartman, Leah
    Pinnock, Farena
    Mashhadi, Farzaneh
    Ciantar, Sarah
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S368 - S368
  • [32] Treatment with rosuvastatin for severe dyslipidaemia in patients with schizophrenia and Schizoaffective disorder
    De Hert, M.
    Kalnicka, D.
    van Winkel, R.
    Wampers, M.
    Hanssens, L.
    Van Eyck, D.
    Scheen, A.
    Peuskens, J.
    DRUG SAFETY, 2006, 29 (10) : 1002 - 1002
  • [33] Combined clozapine-lithium treatment in schizophrenia and schizoaffective disorder
    Moldavsky, M
    Stein, D
    Benatove, R
    Sirota, P
    Weizman, A
    Elizur, A
    SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) : VA10 - VA10
  • [34] Risperidone versus olanzapine in the treatment of patients with schizophrenia or schizoaffective disorder
    Brecher, M
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 271 - 271
  • [35] KNOWLEDGE OF THE TREATMENT IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER AND ITS RELATIONSHIP WITH NONADHERENCE
    Acosta, Francisco J.
    Vega, Dulcinea
    Saavedra, Pedro
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2023, 51 (04): : 157 - 166
  • [36] CLOZAPINE IN THE TREATMENT OF PSYCHOTIC MOOD DISORDERS, SCHIZOAFFECTIVE DISORDER, AND SCHIZOPHRENIA
    MCELROY, SL
    DESSAIN, EC
    POPE, HG
    COLE, JO
    KECK, PE
    FRANKENBERG, FR
    AIZLEY, HG
    OBRIEN, S
    JOURNAL OF CLINICAL PSYCHIATRY, 1991, 52 (10) : 411 - 414
  • [37] Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder
    De Hert, Marc
    Kalnicka, Dita
    van Winkel, Ruud
    Wampers, Martien
    Hanssens, Linda
    Van Eyck, Dominique
    Scheen, Andre
    Peuskens, Joseph
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (12) : 1889 - 1896
  • [38] CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder
    Sharma, RP
    Janicak, PG
    Bissette, G
    Nemeroff, CB
    AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (07): : 1019 - 1021
  • [39] Pharmacological treatment of schizophrenia and schizoaffective disorder - focused on combinations of antipsychotics
    Ustohal, L.
    Prikryl, R.
    Kucerova, H. Prikrylova
    Vrzalova, M.
    Kasparek, T.
    Ceskova, E.
    Stehnova, I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 138 - 139
  • [40] Treatment with rosuvastatin for severe dyslipidaemia in patients with schizophrenia and schizoaffective disorder
    De Hert, M. A.
    van Winkel, R.
    Wampers, M.
    Van Eyck, D.
    Hanssens, L.
    Scheen, A.
    Peuskens, J.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 498 - 498